The regulation of
estrogenic and anti
estrogenic effects by selective
estrogen receptormodulators (SERMs) provides the basis for use in long-term therapy in cancer chemopreventionand postmenopausal osteoporosis. However, the evidence for carcinogenic properties withinthis class requires study of potential pathways of toxicity. There is strong evidence for theelevation of cellular levels of NO in tissue treated with SERMs, including the benzothiophenederivative, raloxifene, in part via up-regulation of nitric oxide synthases. Therefore, thereactions of 17
-estradiol (E
2), raloxifene, and an isomer with NO, peroxynitrite, and reactivenitrogen/oxygen species (RNOS) generated from NO
2-/H
2O
2 systems were examined. Peroxynitrite from bolus injection or slow release from higher concentrations of 3-morpholinosydnonimine (SIN-1) reacted with the benzothiophenes and E
2 to give aromatic ring nitration,whereas peroxynitrite, produced from the slow
decomposition of lower concentrations of SIN-1, was relatively unreactive toward E
2 and yielded oxidation and nitrosation products withraloxifene and its isomer. The oxidation and nitrosation products formed were characterizedas a dimer and quinone oxime derivative. Interestingly, the reaction of the benzothiopheneswith NO in aerobic solution efficiently generated the same oxidation products. Stable quinoneoximes are not unprecedented but have not been previously reported as products of RNOS-mediated metabolism. The reaction of glutathione (GSH) with the quinone oxime gave bothGSH adducts from Michael addition and reduction to the corresponding
o-aminophenol. Theready autoxidation of raloxifene, observed in the presence of NO, is the first such observationon the reactivity of SERMs and is potentially a general phenomenon of significance to SERMchemical toxicology.